A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections; Cytomegalovirus infections; Monkeypox; Smallpox; Viral infections
- Focus Adverse reactions
- Sponsors Chimerix
- 08 Nov 2017 According to a Chimerix media release, data will be reported in early 2018.
- 07 Aug 2017 Status changed from planning to recruiting according to a Chimerix media release.
- 17 May 2017 New trial record